Shire Sues Sandoz, Amneal Over Vyvanse ANDA

Law360, New York (July 1, 2011, 7:46 PM EDT) -- Shire PLC sued Sandoz Inc. and Amneal Pharmaceuticals LLC in New Jersey federal court Friday over their efforts to make generic versions of ADHD treatment Vyvanse.

The global pharmaceutical company accuses the generic-drug makers in separate suits of infringing the 16 patents covering Vyvanse by filing an abbreviated new drug application with the U.S. Food and Drug Administration for their own version of the drug.

“The lawsuits were initiated in response to ANDAs filed by Amneal and Sandoz seeking FDA approval to market and sell generic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.